Published in Hepatology on June 01, 2007
Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. World J Gastroenterol (2010) 1.00
Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study. Crit Care (2012) 0.99
Cerebral net exchange of large neutral amino acids after lipopolysaccharide infusion in healthy humans. Crit Care (2010) 0.94
Acute-on-Chronic Liver Failure. Clin Gastroenterol Hepatol (2015) 0.92
Suppression of the HPA axis during extrahepatic biliary obstruction induces cholangiocyte proliferation in the rat. Am J Physiol Gastrointest Liver Physiol (2011) 0.91
Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation. J Clin Exp Hepatol (2014) 0.91
Marked potentiation of cell swelling by cytokines in ammonia-sensitized cultured astrocytes. J Neuroinflammation (2010) 0.89
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia. World J Hepatol (2015) 0.88
Pathogenesis of hepatic encephalopathy. Gastroenterol Res Pract (2012) 0.88
Pathogenesis of brain edema and investigation into anti-edema drugs. Int J Mol Sci (2015) 0.88
Increased toll-like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy. J Neurochem (2013) 0.85
Clinical and Pathophysiological Consequences of Alterations in the Microbiome in Cirrhosis. Am J Gastroenterol (2015) 0.85
Liver involvement in systemic infection. World J Hepatol (2014) 0.84
Gut microbiota: its role in hepatic encephalopathy. J Clin Exp Hepatol (2014) 0.83
Blood-brain barrier in acute liver failure. Neurochem Int (2011) 0.83
Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension. J Hepatol (2014) 0.83
Role of cerebral endothelial cells in the astrocyte swelling and brain edema associated with acute hepatic encephalopathy. Neuroscience (2012) 0.81
Hyperammonemia and systemic inflammatory response syndrome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shunts. PLoS One (2014) 0.78
Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure. Am J Pathol (2015) 0.78
The brain in acute on chronic liver failure. Metab Brain Dis (2014) 0.78
Bile duct-ligated mice exhibit multiple phenotypic similarities to acute decompensation patients despite histological differences. Liver Int (2015) 0.77
Effects of dexamethasone and cox inhibitors on intracranial pressure and cerebral perfusion in the lipopolysaccharide treated rats with hyperammonemia. PLoS One (2015) 0.75
Evaluation of an ADVanced Organ Support (ADVOS) system in a two-hit porcine model of liver failure plus endotoxemia. Intensive Care Med Exp (2017) 0.75
Acute-on-chronic liver failure: recent update. J Biomed Res (2017) 0.75
Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology (2013) 5.88
Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet (2002) 4.42
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int (2008) 4.16
Dispelling myths in the treatment of hepatic encephalopathy. Lancet (2005) 2.86
Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut (2011) 2.65
Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology (2013) 2.64
Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol (2004) 2.48
Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol (2006) 2.44
Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology (2012) 2.39
Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol (2004) 2.28
Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology (2002) 2.17
Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. Hepatology (2010) 2.15
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology (2013) 2.08
Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology (2007) 2.08
Paracetamol: are therapeutic doses entirely safe? Lancet (2006) 2.07
The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis. J Hepatol (2011) 2.05
Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int (2008) 1.95
Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology (2009) 1.94
Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. J Hepatol (2011) 1.90
Acute myocarditis presenting as acute coronary syndrome: role of early cardiac magnetic resonance in its diagnosis. Heart (2010) 1.85
Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol (2013) 1.83
Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis. Gastroenterology (2008) 1.82
Making and working with hydrogen sulfide: The chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review. Free Radic Biol Med (2009) 1.76
Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol (2003) 1.73
CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology (2015) 1.70
Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival. J Hepatol (2013) 1.70
Diet-induced endogenous formation of nitroso compounds in the GI tract. Free Radic Biol Med (2007) 1.66
'Nipped in the Budd': hepatic venous outflow obstruction in evolution. Eur J Gastroenterol Hepatol (2005) 1.66
Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med (2002) 1.66
Beyond scoring: a modern interpretation of disease progression in chronic liver disease. Gut (2013) 1.63
Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc Natl Acad Sci U S A (2002) 1.63
Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology (2002) 1.60
Effects of hypothermia on brain glucose metabolism in acute liver failure: a H/C-nuclear magnetic resonance study. Gastroenterology (2003) 1.60
Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol (2005) 1.60
Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology (2003) 1.59
Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology (2003) 1.59
Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis. J Hepatol (2002) 1.57
Intensive care of the patient with cirrhosis. Hepatology (2011) 1.54
Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure*. Crit Care Med (2013) 1.51
Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl (2004) 1.50
Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. Crit Care Med (2006) 1.50
The effect of dietary nitrate on salivary, plasma, and urinary nitrate metabolism in humans. Free Radic Biol Med (2003) 1.48
A reproducible, clinically relevant, intensively managed, pig model of acute liver failure for testing of therapies aimed to prolong survival. Liver Int (2013) 1.48
Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease. Am J Hematol (2009) 1.48
Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis. Hepatology (2013) 1.47
Phosphoinositide 3-kinases as drug targets in cancer. Curr Opin Pharmacol (2005) 1.47
pH-dependent nitration of para-hydroxyphenylacetic acid in the stomach. Free Radic Biol Med (2006) 1.47
Transjugular intrahepatic portosystemic stent-shunt in the management of gastric and ectopic varices. Eur J Gastroenterol Hepatol (2006) 1.45
Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol (2003) 1.45
Binding of bilirubin and bromosulphthalein to albumin: implications for understanding the pathophysiology of liver failure and its management. Liver Transpl (2004) 1.43
Hemostasis in patients with acute kidney injury secondary to acute liver failure. Kidney Int (2013) 1.43
Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs. Intensive Care Med (2004) 1.41
The role of α7 nicotinic acetylcholine receptor in modulation of heart rate dynamics in endotoxemic rats. PLoS One (2013) 1.41
Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology (2002) 1.41
Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia. Am J Hematol (2005) 1.41
Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif (2002) 1.41
Protein synthesis is severely diminished following a simulated upper GI bleed in patients with cirrhosis. J Hepatol (2008) 1.39
Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure. Proc Natl Acad Sci U S A (2010) 1.35
L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure. Hepatology (2009) 1.33
Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control. Antiviral Res (2003) 1.31
Evaluation of coagulation abnormalities in acute liver failure. J Hepatol (2012) 1.29
CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol (2009) 1.27
Aromatic amino acid metabolism during liver failure. J Nutr (2007) 1.26
L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats. Hepatology (2009) 1.25
The pathophysiological basis of acute-on-chronic liver failure. Liver (2002) 1.24